Related Experiment Video
Updated: Jul 1, 2025

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
TNF in Human Tuberculosis: A Double-Edged Sword
Jae-Min Yuk1,2,3, Jin Kyung Kim4, In Soo Kim2,5
1Infection Control Convergence Research Center, Chungnam National University College of Medicine, Daejeon 35015, Korea.
Tumor necrosis factor (TNF) plays a dual role in tuberculosis (TB) infection, aiding protective immunity but also contributing to pathology. Understanding TNF signaling is crucial for developing targeted therapies against TB.
Area of Science:
- Immunology
- Infectious Diseases
- Cell Biology
Background:
- Tumor necrosis factor (TNF) is a key proinflammatory cytokine in Mycobacterium tuberculosis (Mtb) infection.
- TNF influences protective immunity and immunopathology during tuberculosis (TB).
- Phagocytes in the lungs are primary producers of TNF in early Mtb infection.
Purpose of the Study:
- To review the multifaceted role of TNF in TB pathogenesis and prevention.
- To highlight the importance of investigating TNF and its receptor functions in TB immunity and pathology.
- To guide the development of targeted therapeutic strategies for TB.
Main Methods:
- Literature review of TNF's role in Mycobacterium tuberculosis infection.
- Analysis of TNF's functions in granuloma formation and immune cell recruitment.
- Examination of TNF's contribution to both protective immunity and disease pathology.
Main Results:
- TNF is essential for granuloma formation, chronic infection control, and macrophage activation.
- TNF, with chemokines, aids in initiating, maintaining, and clearing mycobacteria in granulomas.
- Anti-TNF therapy, while effective for other diseases, risks TB reactivation and contributes to TB-associated cachexia.
Conclusions:
- TNF signaling has both beneficial and detrimental effects in TB pathogenesis.
- Further investigation into TNF and its receptors is vital for understanding TB immunity.
- Targeting TNF signaling pathways may offer novel therapeutic approaches for TB.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
07:42Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...